Average Co-Inventor Count = 8.29
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Merck + Co., Inc. (3 from 4,770 patents)
3. Merck Sharp & Dohme LLC (6 patents)
18 patents:
1. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
2. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
3. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
4. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
5. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
6. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
7. 10968193 - Antidiabetic bicyclic compounds
8. 10662171 - Antidiabetic bicyclic compounds
9. 10131651 - [7,6]-fused bicyclic antidiabetic compounds
10. 10100042 - [5,6]—fused bicyclic antidiabetic compounds
11. 10059667 - Antidiabetic compounds
12. 10000454 - Antidiabetic tricyclic compounds
13. 9957219 - Antidiabetic bicyclic compounds
14. 9840512 - Antidiabetic bicyclic compounds
15. 9527875 - Antidiabetic tricyclic compounds